메뉴 건너뛰기
New England Journal of Medicine
Volumn 365, Issue 15, 2011, Pages 1454-1455
The Avastin story
Author keywords

[No Author keywords available]
Indexed keywords

BEVACIZUMAB; PACLITAXEL;
EID: 80054016807     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1109550     Document Type: Letter
Times cited : (17)
References (3)
  • 1
    • 79960240479 scopus 로고    scopus 로고
    • Reputation and precedent in the bevacizumab decision
    • Carpenter D, Kesselheim AS, Joffe S. Reputation and precedent in the bevacizumab decision. N Engl J Med 2011;365(2):e3.
    • (2011) N Engl J Med , vol.365 , Issue.2
    • Carpenter, D.1    Kesselheim, A.S.2    Joffe, S.3
  • 2
    • 79960241809 scopus 로고    scopus 로고
    • Changing end points in breast-cancer drug approval - The Avastin story
    • D'Agostino RB Sr. Changing end points in breast-cancer drug approval - the Avastin story. N Engl J Med 2011;365(2):e2.
    • (2011) N Engl J Med , vol.365 , Issue.2
    • D'Agostino Sr., R.B.1
  • 3
    • 37549040613 scopus 로고    scopus 로고
    • Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
    • Miller K, Wang M, Gralow J, et al. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med 2007;357:2666-76.
    • (2007) N Engl J Med , vol.357 , pp. 2666-2676
    • Miller, K.1    Wang, M.2    Gralow, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.